Home
/
EXOZYMES INC.
/
Financials
/
Quarterly
EXOZYMES INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that EXOZYMES INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2023
$70.8K
Nov 12, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.29M)
Nov 13, 2025
Q3
2025
Jun 30, 2025
($2.36M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($2.36M)
Aug 12, 2025
Q2
2025
Mar 31, 2025
($1.86M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($1.86M)
May 12, 2025
Q3
2025
Mar 31, 2025
($1.86M)
Nov 13, 2025
Q3
2025
Sep 30, 2024
($1.66M)
Nov 13, 2025
Q3
2025
Jun 30, 2024
($1.36M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($1.36M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($1.01M)
May 12, 2025
Q2
2025
Mar 31, 2024
($1.01M)
Aug 12, 2025
Q3
2025
Mar 31, 2024
($1.01M)
Nov 13, 2025
Q3
2024
Sep 30, 2023
($520.6K)
Nov 12, 2024
Q3
2024
Jun 30, 2023
($178.1K)
Nov 12, 2024
Q3
2024
Mar 31, 2023
($241.2K)
Nov 12, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.52M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($2.55M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($1.95M)
May 12, 2025
Q3
2025
Sep 30, 2024
($1.61M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($1.33M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($1.01M)
May 12, 2025
Q3
2024
Sep 30, 2023
($391.8K)
Nov 12, 2024